Jin Medical International
ZJYL
ZJYL was delisted on the 31st of July, 2026.
2 hedge funds and large institutions have $326K invested in Jin Medical International in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
83% more capital invested
Capital invested by funds: $178K → $326K (+$148K)
0.06% more ownership
Funds ownership: 0.31% → 0.37% (+0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$29.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.67K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Nomura Holdings
Tokyo,
Japan
| $318K | +$29.6K | +3,901 | +16% |
|
|
2
UBS Group
Zurich,
Switzerland
| $8.51K | +$5.67K | +746 | New |
|
ZJYL Hedge Fund Activity: Q2 2023 in Review
2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q2 2023, worth a combined $326K — up 83% from $178K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ZJYL positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Nomura Holdings, adding an estimated $29.6K.
- 2 institutional investors held Jin Medical International (ZJYL) as of Q2 2023, up from 1 in Q1 2023.
- Funds reported $326K of Jin Medical International stock for Q2 2023, up 83% quarter-over-quarter.
- 1 fund opened new Jin Medical International positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Jin Medical International buyer in Q2 2023 was Nomura Holdings, an estimated $29.6K added.
Based on aggregated 13F filings for Q2 2023.